0001437749-26-004395
SEC filingReposiTrak, Inc. reported solid financial results for Q2 2026 (period ending December 31, 2025). Revenue was $5.9 million, with income from operations of $1.8 million and net income of $1.7 million. The company generated strong operating cash flow of $3.8 million, though net cash decreased by $138,000 due to significant financing activities including $1.2 million in common stock buybacks and $1.5 million in Series B Preferred redemptions. Key profitability metrics show healthy margins, with the company maintaining a strong balance sheet featuring $28.7 million in cash, total assets of $56.3 million, and stockholders' equity of $49.7 million against total liabilities of only $6.6 million. The company's financial position remains robust with substantial liquidity.
ReposiTrak, Inc. delivered solid financial performance for Q2 2026 (period ending December 31, 2025). The company reported revenue of $5.9 million, with income from operations of $1.8 million and net income of $1.7 million. Total comprehensive income was also $1.7 million. The company generated $3.8 million in net cash from operating activities, demonstrating strong cash conversion from operations. However, net cash decreased by $138,000 due to significant financing outflows including $1.2 million in common stock buybacks, $1.5 million in Series B Preferred redemptions, and $827,000 in dividends paid. The balance sheet remains strong with $28.7 million in cash and total assets of $56.3 million.
Revenue for the quarter was $5.9 million. The document does not provide segment breakdown, geographic mix, or specific growth drivers beyond the aggregate revenue figure. No comparative period revenue data is provided in the XBRL data or document text, preventing calculation of growth rates or trend analysis. The revenue appears to be generated from the company's core operations, but without segment disclosure, detailed revenue composition analysis is not possible based on the provided information.
The company demonstrated healthy profitability with income from operations of $1.8 million on revenue of $5.9 million, representing an operating margin of 30.5%. Total operating expenses were $4.0 million, consisting of cost of revenue and product support ($854,000), sales and marketing ($1.5 million), general and administrative ($1.5 million), and depreciation and amortization ($224,000). Net income was $1.7 million after interest income of $397,000, interest expense of $9,000, unrealized loss on short-term investments of $69,000, and income tax provision of $450,000. No prior period margin data is provided for comparison.
The company generated strong operating cash flow of $3.8 million, driven by net income of $1.7 million plus adjustments including depreciation and amortization of $468,000 and stock compensation expense of $257,000. Investing activities used $20,000 primarily for property and equipment purchases. Financing activities used $3.6 million for stock buybacks, preferred stock redemptions, and dividend payments. The balance sheet shows total assets of $56.3 million including $28.7 million in cash, $4.9 million in receivables, and $20.9 million in goodwill. Total liabilities are only $6.6 million, resulting in stockholders' equity of $49.7 million and a strong equity-to-assets ratio of 88.3%.
The document does not contain management guidance, strategic priorities, or specific risk factors beyond the financial statements. No forward-looking statements, business outlook, or strategic initiatives are disclosed in the provided content. The filing appears to contain only financial statement data without accompanying management discussion and analysis (MD&A) that would typically include outlook information. Therefore, no outlook commentary can be provided based on the available information.